These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33107978)

  • 1. Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated.
    Sears AV; Woolf RT; Gribaleva E; Abdelrahman W; Robbie S; Menon B; Kirkham B; Smith CH; Pink AE
    Br J Dermatol; 2021 Apr; 184(4):755-757. PubMed ID: 33107978
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis.
    Halling AS; Loft N; Silverberg JI; Guttman-Yassky E; Thyssen JP
    J Am Acad Dermatol; 2021 Jan; 84(1):139-147. PubMed ID: 32822798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
    Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
    BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world persistence with dupilumab among adults with atopic dermatitis.
    Silverberg JI; Guttman-Yassky E; Gadkari A; Kuznik A; Mallya UG; Mastey V; Zhang H; Chen Z; Chen C; Korotzer A; Sierka D; Fenton MC; Kaur M; Jalbert JJ
    Ann Allergy Asthma Immunol; 2021 Jan; 126(1):40-45. PubMed ID: 32739313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ocular symptoms associated with dupilumab in atopic dermatitis].
    Voorberg AN; Oosterhaven JAF; Wijdh RHJ; de Bruin-Weller MS; Schuttelaar MLA
    Ned Tijdschr Geneeskd; 2019 Mar; 163():. PubMed ID: 30945835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.
    Liberman P; Shifera AS; Berkenstock M
    Cornea; 2020 Jun; 39(6):784-786. PubMed ID: 31985517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosacea associated with dupilumab therapy.
    Heibel HD; Hendricks AJ; Foshee JP; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
    [No Abstract]   [Full Text] [Related]  

  • 8. Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.
    Benzecry V; Pravettoni V; Segatto G; Marzano AV; Ferrucci S
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):261-263. PubMed ID: 32732182
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness and safety of dupilumab for atopic dermatitis in a liver transplant recipient: a case report.
    Ludriksone L; Elsner P; Malessa C; Settmacher U; Schliemann S
    J Dtsch Dermatol Ges; 2020 Jul; 18(7):740-742. PubMed ID: 32212242
    [No Abstract]   [Full Text] [Related]  

  • 10. Onset of Schamberg Disease and Resolution of Alopecia Areata During Treatment of Atopic Dermatitis With Dupilumab.
    Szekely S; Vaccari D; Salmaso R; Belloni-Fortina A; Alaibac M
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):65-66. PubMed ID: 32490817
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre.
    Olesen CM; Holm JG; Nørreslet LB; Serup JV; Thomsen SF; Agner T
    J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):1562-1568. PubMed ID: 30959559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials.
    Blauvelt A; Rosmarin D; Bieber T; Simpson EL; Bagel J; Worm M; Deleuran M; Katoh N; Kawashima M; Shumel B; Chen Z; Rossi AB; Hultsch T; Ardeleanu M
    Br J Dermatol; 2019 Jul; 181(1):196-197. PubMed ID: 30719707
    [No Abstract]   [Full Text] [Related]  

  • 13. Dupixent® (Dupilumab): A Newly Approved Interleukin-4 Receptor Antagonist for the Treatment of Atopic Dermatitis in Pediatric Patients.
    Gupta AK; Love RP; Abramovits W; Vincent KD
    Skinmed; 2019; 17(2):107-109. PubMed ID: 31145061
    [No Abstract]   [Full Text] [Related]  

  • 14. Two cases of psoriasiform dermatitis arising during dupilumab therapy and successfully treated with delgocitinib ointment.
    Kurihara K; Fujiyama T; Tokura Y; Honda T
    Eur J Dermatol; 2021 Oct; 31(5):658-660. PubMed ID: 34704949
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of Sézary syndrome following the administration of dupilumab.
    Tran J; Morris L; Vu A; Duvic M
    Dermatol Online J; 2020 Apr; 26(4):. PubMed ID: 32621690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of increased risk for Coronavirus Disease 2019 (COVID-19) in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy.
    Carugno A; Raponi F; Locatelli AG; Vezzoli P; Gambini DM; Di Mercurio M; Robustelli Test E; Sena P
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e433-e434. PubMed ID: 32339362
    [No Abstract]   [Full Text] [Related]  

  • 17. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
    Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
    J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab for the Treatment of Atopic Dermatitis.
    Ferreira S; Torres T
    Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):230-240. PubMed ID: 29422431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canalicular stenosis associated with dupilumab treatment for atopic dermatitis.
    Loret L; Ninclaus V; Dendooven A; Lapeere H; Kreps EO
    Eur J Dermatol; 2021 Dec; 31(6):843-844. PubMed ID: 34933837
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience.
    Ribero S; Giura MT; Viola R; Ramondetta A; Siliquini N; Cardone P; Tonella L; Quaglino P; Dapavo P; Panzone M; Ortoncelli M; Fierro MT
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e380-e383. PubMed ID: 31960496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.